Cibus, Inc.

General ticker "CBUS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $44.0M (TTM average)

Cibus, Inc. follows the US Stock Market performance with the rate: 16.2%.

Estimated limits based on current volatility of 7.2%: low 1.72$, high 1.99$

Factors to consider:

  • Total employees count: 183 as of 2023
  • Price in estimated range
  • Earnings for 12 months up through Q4 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.05$, 4.60$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.76$, 3.20$]

Financial Metrics affecting the CBUS estimates:

  • Positive: with PPE of -0.9 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -88.48 <= 0.01
  • Positive: Return on assets ratio (scaled to [-100,100]) of 44.68 > 6.11
  • Positive: 19.40 < Shareholder equity ratio, % of 26.33 <= 42.68
  • Positive: -4.43 < Investing cash flow per share per price, % of -1.23

Similar symbols

Short-term CBUS quotes

Long-term CBUS plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.16MM $1.82MM $4.26MM
Operating Expenses $22.53MM $320.70MM $262.66MM
Operating Income $-22.37MM $-318.88MM $-258.40MM
Non-Operating Income $5.48MM $-18.76MM $-24.29MM
Interest Expense $0.09MM $18.89MM $34.19MM
R&D Expense $11.55MM $42.37MM $50.43MM
Income(Loss) $-16.89MM $-337.64MM $-282.68MM
Taxes $0.00MM $-0.00MM $-0.03MM
Profit(Loss)* $-16.89MM $-267.63MM $-251.39MM
Stockholders Equity $7.23MM $293.47MM $92.16MM
Assets $22.42MM $544.41MM $350.07MM
Operating Cash Flow $-19.36MM $-46.21MM $-58.04MM
Capital expenditure $1.52MM $4.32MM $0.81MM
Investing Cash Flow $-1.52MM $55.06MM $-0.81MM
Financing Cash Flow $9.99MM $20.32MM $40.60MM
Earnings Per Share** $-0.03 $-25.95 $-10.83

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.